---
figid: PMC8989557__JO2022-8901326.002
figtitle: Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
- Drosophila melanogaster
pmcid: PMC8989557
filename: JO2022-8901326.002.jpg
figlink: /pmc/articles/PMC8989557/figure/fig2/
number: F2
caption: Multiple pathways of tumor immune escape mechanism. (a) IFN-γ--JAK1/JAK2-STAT1/2/3-IRF1
  axis mainly regulates the expression of PD-L1 []. If the expression of IFN-γ increases,
  the expression of PD-L1 will increase. The PD-1/PD-L1 pathway was activated and
  induced T cell inactivation. (b) IFN-γ activates CTLA-4 expression through phosphorylation
  of Jak1/2-STAT1 and then competes with CD28 to bind to B7 [] that inhibits T cell
  activation. (c) IDO suppresses the immune response by metabolizing tryptophan [].
  Its metabolites inhibit T cell activation and promote tumor proliferation. (d) IDO
  expression in THP-1 cells increased M2-type cell polarization []. M2-type macrophages
  inhibit the immune system and promote tumor proliferation and metastasis. (e) T
  cells combine with tumor-associated antigens expressed by tumor cells to exert an
  immune effect.
papertitle: Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy.
reftext: Nasrin Aktar, et al. J Oncol. 2022;2022:8901326.
year: '2022'
doi: 10.1155/2022/8901326
journal_title: Journal of Oncology
journal_nlm_ta: J Oncol
publisher_name: Hindawi
keywords: ''
automl_pathway: 0.9471038
figid_alias: PMC8989557__F2
figtype: Figure
redirect_from: /figures/PMC8989557__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8989557__JO2022-8901326.002.html
  '@type': Dataset
  description: Multiple pathways of tumor immune escape mechanism. (a) IFN-γ--JAK1/JAK2-STAT1/2/3-IRF1
    axis mainly regulates the expression of PD-L1 []. If the expression of IFN-γ increases,
    the expression of PD-L1 will increase. The PD-1/PD-L1 pathway was activated and
    induced T cell inactivation. (b) IFN-γ activates CTLA-4 expression through phosphorylation
    of Jak1/2-STAT1 and then competes with CD28 to bind to B7 [] that inhibits T cell
    activation. (c) IDO suppresses the immune response by metabolizing tryptophan
    []. Its metabolites inhibit T cell activation and promote tumor proliferation.
    (d) IDO expression in THP-1 cells increased M2-type cell polarization []. M2-type
    macrophages inhibit the immune system and promote tumor proliferation and metastasis.
    (e) T cells combine with tumor-associated antigens expressed by tumor cells to
    exert an immune effect.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ido1
  - H2-Aa
  - Ugt2b5
  - Jak1
  - Jak2
  - Pdcd1
  - Ctla4
  - Cd28
  - Dnd1
  - Cd274
  - Cd86
  - Apcs
  - ag
  - Stat2
  - Stat1
  - Stat3
  - IDO1
  - GLI2
  - JAK1
  - JAK2
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CTLA4
  - CD28
  - TERC
  - TECR
  - CD274
  - CD86
  - APCS
  - HLA-C
  - STAT2
  - STAT1
  - STAT3
  - ido1
  - jak1
  - jak2b
  - cd28
  - si:ch211-241b2.5
  - apcs
  - stat2
  - stat1a
  - stat1b
  - stat4
  - stat3
  - Pa
  - aa
  - ter
  - term
  - Mhc
  - zip
---
